Researchers at the University of Nebraska Medical Center co-published a recent article in the American Journal of Men’s Health that shows men and their health care providers are not having important discussions when it comes to prostate cancer screening and treatment. Urologist, Dr. Chad LaGrange one of the findings in the study showed the value of establishing a good relationship with a physician.

LaGrange says they looked at 1,700 patient questionnaires nationwide and asked questions about the prostate specific antigen screening which is a simple blood test. They also looked at whether physicians were going over the risks and benefits of the screening and if treatment was discussed.

The results show that 17% of patents were told some experts disagree about whether men should have the blood test, 23% were told some types of prostate cancer are slow-growing and need no treatment and 25% were told the blood test isn’t always accurate in diagnosing prostate cancer.